Chemoinformaics analysis of Ethyl nonadecanoate
| Molecular Weight | 326.565 | nRot | 18 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 1 |
| Exact Molecular Weight | 326.318 | nRing | 0 |
| Solubility: LogS | -7.03 | nHRing | 0 |
| Solubility: LogP | 8.695 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 64.6793 |
| nHD | 0 | BPOL | 44.7387 |
| QED | 0.196 |
| Synth | 1.778 |
| Natural Product Likeliness | 0.106 |
| NR-PPAR-gamma | 0.101 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.903 |
| MDCK | 0.0000129 |
| BBB | 0.064 |
| PPB | 0.972689 |
| VDSS | 2.765 |
| FU | 0.0136543 |
| CYP1A2-inh | 0.203 |
| CYP1A2-sub | 0.174 |
| CYP2c19-inh | 0.349 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.031 |
| CYP3a4-inh | 0.276 |
| CYP3a4-sub | 0.05 |
| CL | 4.425 |
| T12 | 0.142 |
| hERG | 0.315 |
| Ames | 0.005 |
| ROA | 0.026 |
| SkinSen | 0.962 |
| Carcinogencity | 0.043 |
| EI | 0.948 |
| Respiratory | 0.891 |
| NR-Aromatase | 0.089 |
| Antiviral | No |
| Prediction | 0.57003 |